Jeevan Scientific Technology Limited has announced a board meeting today.

The board approved the financial results for the quarter, reporting a consolidated loss of 3.22 Cr, compared to a profit of 1.03 Cr in the same quarter last year.

Key management changes include the re-appointment of Mr. Krishna Kishore Kuchipudi as MD for 3 years, starting April 1, 2026, at Rs 9 lakh monthly, and the appointment of Mr. Gollapinni Mallikarjuna as a new Independent Director.

Two other directors were re-appointed for rotation, while Mr. Thammareddy Ravi resigned.

The company also approved granting 300,000 stock options to eligible employees and will hold its Annual General Meeting for FY24-25 on September 27, 2025.